Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery Disease
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70195 ↗At a glance
Journal article in Clinical Transplantation, 2025. Written by Lukas Köster and 12 co-authors. Institution: Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Major MEDLINE topics: Heart Transplantation, Biomarkers, Coronary Artery Disease, Natriuretic Peptide, Brain. Cited 4 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Cardiac allograft vasculopathy (CAV) remains a barrier to long‐term survival after heart transplantation. Little is known about cardiovascular biomarkers in CAV and how they compare to biomarkers in atherosclerotic coronary artery disease (CAD).
Purpose
This study addresses these gaps by investigating the associations of high‐sensitivity troponin I and T (hsTnI/T), N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) and high‐sensitivity C‐reactive protein (hsCRP) with CAV and CAD.
Methods
Posttransplant patients undergoing angiography were matched 1:2 with nontransplant patients by age, sex, hypertension, BMI and angiographic severity of CAV and CAD. Disease severity was classified using the International Society for Heart and Lung Transplantation.
Results
Sixty‐three transplant and 126 matched nontransplant patients (median age 55.9 years, 5.8 years posttransplant, 8.5% female) were analyzed. Among transplant patients, 17.5% had mild, 7.9% moderate, 7.9% severe, and 66.7% no CAV. HsTnI/T (OR per SD = 2.21/2.38, CI = 1.17–4.66/1.21–5.69, p = 0.022/0.026) and NT‐proBNP (OR per SD = 2.86, 95% CI 1.50–6.39, p = 0.004) were significantly associated with CAV. While hsTnT (OR per SD = 1.60, 95% CI 1.06–2.52, p = 0.030) and hsCRP (OR per SD = 1.61, 95% CI 1.08–2.47, p = 0.023) were significantly associated with CAD.
Conclusion
Distinct biomarker profiles were observed: HsTnI, hsTnT, and NT‐proBNP showed associations with CAV, while hsTnT and hsCRP were associated with CAD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.
- Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, University Medical Center, Hamburg, Germany.
- Center for Population Health Innovation (POINT Institute), University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
ORCID profiles: Lukas Köster, Thiess Lorenz, Christina Magnussen
Cite
APA
Köster, L., Weimann, J., Bernhard, A., Bay, B., Blaum, C. M., Lorenz, T., Zeller, T., Waldeyer, C., Reichenspurner, H., Kirchhof, P., Blankenberg, S., Magnussen, C., & Brunner, F. J. (2025). Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery Disease. Clinical Transplantation. https://doi.org/10.1111/ctr.70195
Vancouver
Köster L, Weimann J, Bernhard A, Bay B, Blaum CM, Lorenz T, et al. Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery Disease. Clinical Transplantation. 2025. doi:10.1111/ctr.70195
BibTeX
@article{Kster2025,
author = {Köster, Lukas and Weimann, Jessica and Bernhard, Alexander and Bay, Benjamin and Blaum, Christopher M and Lorenz, Thiess and Zeller, Tanja and Waldeyer, Christoph and Reichenspurner, Hermann and Kirchhof, Paulus and Blankenberg, Stefan and Magnussen, Christina and Brunner, Fabian J},
title = {Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery Disease},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70195}
}
EUVIMED